Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 29.65B | 38.72B | 19.55B | 16.27B | 14.17B | 11.53B |
Gross Profit | 29.65B | 22.30B | 20.18B | 16.27B | 14.17B | 11.53B |
EBITDA | 10.28B | 13.71B | 0.00 | 10.08B | 8.45B | 0.00 |
Net Income | 11.25B | 11.29B | 10.06B | 8.19B | 6.80B | 4.72B |
Balance Sheet | ||||||
Total Assets | 841.90B | 827.22B | 739.30B | 743.37B | 686.07B | 649.94B |
Cash, Cash Equivalents and Short-Term Investments | 141.23B | 139.06B | 117.67B | 114.30B | 107.75B | 101.48B |
Total Debt | 76.30B | 64.90B | 24.59B | 47.08B | 53.86B | 17.76B |
Total Liabilities | 773.29B | 758.39B | 677.05B | 686.30B | 628.36B | 595.29B |
Stockholders Equity | 68.56B | 68.79B | 62.06B | 56.89B | 57.53B | 54.63B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 14.43B | 4.45B | 2.10B | 7.16B | 24.33B |
Operating Cash Flow | 0.00 | 15.34B | 5.17B | 2.77B | 7.73B | 24.88B |
Investing Cash Flow | 0.00 | -1.24B | 727.00M | -694.00M | -1.60B | -415.00M |
Financing Cash Flow | 0.00 | -6.60B | -9.19B | -3.89B | -2.58B | -2.37B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $78.04B | 13.56 | 10.78% | 3.28% | 3.60% | 22.68% | |
77 Outperform | $113.58B | 13.24 | 17.10% | 3.83% | 4.50% | 8.21% | |
73 Outperform | $72.83B | 10.19 | 20.54% | 6.09% | 5.44% | 2.81% | |
71 Outperform | $110.44B | 17.38 | 16.26% | 0.84% | 17.32% | 12.99% | |
68 Neutral | $167.06B | 20.76 | 13.57% | 0.20% | 2.48% | 0.37% | |
65 Neutral | $79.63B | 13.78 | ― | 2.57% | -2.22% | 24.37% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |